Dashboard
Manage Tickers

KHTRFKNIGHT THERAPEUTICS INTERNA...

N/A


$ 0.13 (2.94 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 476.11 $ 0.14 (0.03 %)
DIA $ 418.79 $ 0.80 (0.19 %)
SPY $ 565.17 $ 0.04 (0.01 %)
TLT $ 101.51 $ 0.13 (0.12 %)
GLD $ 237.78 $ -0.20 (-0.08 %)
$ 4.55
-- x --
-- x --
-- - --
$ 3.20 - $ 4.55
3,100
na
0
$ 0.73
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Raymond James Maintains Outperform on Knig...
03/06/2024 17:23:08

Raymond James analyst David Novak maintains Knight Therapeutics (OTC:KHTRF) with a Outperform and raises the price target fr...

knight-therapeutics-secures-rights-to-rigels-fostamatinib-in-latin-america
Knight Therapeutics Secures Rights To Rige...
05/24/2022 20:13:12

Knight Therapeutics Inc. (TSX: GUD) (OTC: KHTRF) 

puma-biotechs-nerlynx-wins-canadian-approval-in-her2-positive-metastatic-breast-cancer
Puma Biotech's Nerlynx Wins Canadian Appro...
07/06/2021 14:23:57

Core News & Articles
Stocks That Hit 52-Week Lows On Wednesday
02/26/2020 16:14:39

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION